Novelix Pharmaceuticals Ltd

Novelix Pharma EGM Results: Key Decisions & Voting Breakdown 📊

- Held Extraordinary General Meeting (EGM) on January 09, 2026 via video conferencing.

- Total shareholders as of cutoff date (Jan 2, 2026): 3,085.

- 3 Promoters and 61 Public shareholders attended virtually.

- Resolution 1: Equity share issuance (preferential basis) passed with 100% votes. Promoters voted 95.47% of their holdings (8,422,733 shares), Public non-institutions voted 23.56% (1,724,405 shares).

- Resolution 2: Ms. Sridevi Belide appointed as Non-Executive Director with 100% approval. Total votes cast: 10,147,138 (62.87% of outstanding shares).

- Scrutinizer confirmed all resolutions passed unanimously—no votes against.